MAA
NKTR icon

Managed Account Advisors’s Nektar Therapeutics NKTR Stock Holding History

Managed Account Advisors’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-140
Closed -$27K – 2710
2014
Q2 		$27K Sell
140
-50
-26% -$8.84K ﹤0.01% 2470
2014
Q1 		$35K Sell
190
-1,055
-85% -$209K ﹤0.01% 2416
2013
Q4 		$212K Buy
1,245
+133
+12% +$21.4K ﹤0.01% 2203
2013
Q3 		$174K Sell
1,112
-19
-2% -$3.51K ﹤0.01% 2162
2013
Q2 		$196K Buy
+1,131
New +$173K ﹤0.01% 2146

Other funds holding NKTR

O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Managed Account Advisors's NKTR Position: Q3 2014 in Review

Managed Account Advisors sold out of Nektar Therapeutics (NKTR) in Q3 2014, closing a stake of 140 shares — an estimated $27K sold.

Managed Account Advisors first reported a position in NKTR in Q2 2013 and held it in 5 quarters. The position peaked at $212K in Q4 2013. 145 funds tracked by Wall St. Rank hold NKTR as of Q3 2014.

  • Managed Account Advisors reported no remaining Nektar Therapeutics position as of Q3 2014 after selling out during the quarter.
  • Managed Account Advisors sold 140 Nektar Therapeutics shares in Q3 2014, an estimated $27K.
  • Managed Account Advisors first reported a position in Nektar Therapeutics in Q2 2013 and held it in 5 quarters.
  • Managed Account Advisors's Nektar Therapeutics position peaked at $212K in Q4 2013.
  • 145 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2014.

Based on Managed Account Advisors's 13F filing for Q3 2014, filed 17 Nov 2014.